Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Apr 1;315(Pt 1):289–293. doi: 10.1042/bj3150289

Epidermal growth factor administration decreases liver glycogen and causes mild hyperglycaemia in mice.

M Grau 1, F Tebar 1, I Ramírez 1, M Soley 1
PMCID: PMC1217184  PMID: 8670120

Abstract

Several laboratories report different effects of epidermal growth factor (EGF) on glycogen metabolism in hepatocytes. The discrepancies may be attributed to differences in the experimental conditions. It is therefore important to establish the actual effect of EGF in vivo. Because large physiological variations of EGF concentration in plasma occur in mice, we used this species to address this question. In freshly isolated mouse hepatocytes, EGF increased glycogen degradation in a dose-dependent manner. The maximal effect (36% increase over basal glycogenolysis) was smaller than maximal effects of classical glycogenolytic hormones like adrenaline or glucagon (more than 150% increase over basal). This is in keeping with the smaller effect of EGF on phosphorylase a activity. In contrast with these hormones, EGF did not inhibit glycolysis. Thus these effects of EGF in mouse hepatocytes are similar to those recently described by us in rat hepatocytes [Quintana, Grau, Moreno, Soler, Ramirez and Soley (1995) Biochem J 308, 889-894]. When administered to whole animals, EGF increased phosphorylase a activity, decreased the glycogen content in the liver and caused mild hyperglycaemia. Taking together the results obtained for isolated cells and for whole animals, we suggest that the glucosyl residues released from glycogen are used mostly by the liver rather than released to the circulation. This would be different from the action of the classical glycogenolytic hormones, adrenaline and glucagon.

Full Text

The Full Text of this article is available as a PDF (380.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanc P., Etienne H., Daujat M., Fabre I., Zindy F., Domergue J., Astre C., Saint Aubert B., Michel H., Maurel P. Mitotic responsiveness of cultured adult human hepatocytes to epidermal growth factor, transforming growth factor alpha, and human serum. Gastroenterology. 1992 Apr;102(4 Pt 1):1340–1350. [PubMed] [Google Scholar]
  2. Bosch F., Bouscarel B., Slaton J., Blackmore P. F., Exton J. H. Epidermal growth factor mimics insulin effects in rat hepatocytes. Biochem J. 1986 Nov 1;239(3):523–530. doi: 10.1042/bj2390523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boussiotis V. A., Barber D. L., Nakarai T., Freeman G. J., Gribben J. G., Bernstein G. M., D'Andrea A. D., Ritz J., Nadler L. M. Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science. 1994 Nov 11;266(5187):1039–1042. doi: 10.1126/science.7973657. [DOI] [PubMed] [Google Scholar]
  4. Byyny R. L., Orth D. N., Cohen S., Doyne E. S. Epidermal growth factor: effects of androgens and adrenergic agents. Endocrinology. 1974 Sep;95(3):776–782. doi: 10.1210/endo-95-3-776. [DOI] [PubMed] [Google Scholar]
  5. Chowdhury M. H., Agius L. Epidermal growth factor counteracts the glycogenic effect of insulin in parenchymal hepatocyte cultures. Biochem J. 1987 Oct 15;247(2):307–314. doi: 10.1042/bj2470307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Conricode K. M., Ochs R. S. Epidermal growth factor and 12-O-tetradecanoylphorbol 13-acetate stimulate lactate production and the pentose phosphate pathway in freshly isolated rat hepatocytes. J Biol Chem. 1990 Dec 5;265(34):20931–20937. [PubMed] [Google Scholar]
  7. Fain J. N., Garcĩa-Sáinz J. A. Adrenergic regulation of adipocyte metabolism. J Lipid Res. 1983 Aug;24(8):945–966. [PubMed] [Google Scholar]
  8. Grau M., Rodríguez C., Soley M., Ramírez I. Relationship between epidermal growth factor in mouse submandibular glands, plasma, and bile: effects of catecholamines and fasting. Endocrinology. 1994 Nov;135(5):1854–1862. doi: 10.1210/endo.135.5.7956907. [DOI] [PubMed] [Google Scholar]
  9. Hwang D. L., Wang S., Chen R. C., Lev-Ran A. Trauma, especially of the submandibular glands, causes release of epidermal growth factor into bloodstream in mice. Regul Pept. 1991 Jul 9;34(3):133–139. doi: 10.1016/0167-0115(91)90172-d. [DOI] [PubMed] [Google Scholar]
  10. Jones D. E., Jr, Tran-Patterson R., Cui D. M., Davin D., Estell K. P., Miller D. M. Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration. Am J Physiol. 1995 May;268(5 Pt 1):G872–G878. doi: 10.1152/ajpgi.1995.268.5.G872. [DOI] [PubMed] [Google Scholar]
  11. Kurachi H., Oka T. Changes in epidermal growth factor concentrations of submandibular gland, plasma and urine of normal and sialoadenectomized female mice during various reproductive stages. J Endocrinol. 1985 Aug;106(2):197–202. doi: 10.1677/joe.0.1060197. [DOI] [PubMed] [Google Scholar]
  12. Llobera M., Herrera E. Effects of starvation on in vivo gluconeogenesis in hypo- and hyperthyroid rats. Endocrinology. 1980 May;106(5):1628–1633. doi: 10.1210/endo-106-5-1628. [DOI] [PubMed] [Google Scholar]
  13. Michalopoulos G. K., Bowen W., Nussler A. K., Becich M. J., Howard T. A. Comparative analysis of mitogenic and morphogenic effects of HGF and EGF on rat and human hepatocytes maintained in collagen gels. J Cell Physiol. 1993 Sep;156(3):443–452. doi: 10.1002/jcp.1041560303. [DOI] [PubMed] [Google Scholar]
  14. Morand C., Rémésy C., Demigné C. Contrôle du métabolisme du glycogène au niveau du foie. Diabete Metab. 1992;18(1 Pt 2):87–95. [PubMed] [Google Scholar]
  15. Moreno F., Pastor-Anglada M., Hollenberg M. D., Soley M. Effects of epidermal growth factor (urogastrone) on gluconeogenesis, glucose oxidation, and glycogen synthesis in isolated rat hepatocytes. Biochem Cell Biol. 1989 Oct;67(10):724–729. doi: 10.1139/o89-108. [DOI] [PubMed] [Google Scholar]
  16. Morgan N. G., Blackmore P. F., Exton J. H. Age-related changes in the control of hepatic cyclic AMP levels by alpha 1- and beta 2-adrenergic receptors in male rats. J Biol Chem. 1983 Apr 25;258(8):5103–5109. [PubMed] [Google Scholar]
  17. Moule S. K., McGivan J. F. Epidermal-growth-factor stimulation of gluconeogenesis in isolated rat hepatocytes involves the inactivation of pyruvate kinase. Biochem J. 1988 Oct 1;255(1):361–364. [PMC free article] [PubMed] [Google Scholar]
  18. Noguchi S., Ohba Y., Oka T. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in mice. J Endocrinol. 1991 Mar;128(3):425–431. doi: 10.1677/joe.0.1280425. [DOI] [PubMed] [Google Scholar]
  19. O'Connor-McCourt M., Soley M., Hayden L. J., Hollenberg M. D. Receptors for epidermal growth factor (urogastrone) and insulin in primary cultures of rat hepatocytes maintained in serum-free medium. Biochem Cell Biol. 1986 Aug;64(8):803–810. doi: 10.1139/o86-108. [DOI] [PubMed] [Google Scholar]
  20. O'Keefe E., Hollenberg M. D., Cuatrecasas P. Epidermal growth factor. Characteristics of specific binding in membranes from liver, placenta, and other target tissues. Arch Biochem Biophys. 1974 Oct;164(2):518–526. doi: 10.1016/0003-9861(74)90062-9. [DOI] [PubMed] [Google Scholar]
  21. Peak M., Agius L. Inhibition of glycogen synthesis by epidermal growth factor in hepatocytes. The role of cell density and pertussis toxin-sensitive GTP-binding proteins. Eur J Biochem. 1994 Apr 1;221(1):529–536. doi: 10.1111/j.1432-1033.1994.tb18765.x. [DOI] [PubMed] [Google Scholar]
  22. Quintana I., Grau M., Moreno F., Soler C., Ramírez I., Soley M. The early stimulation of glycolysis by epidermal growth factor in isolated rat hepatocytes is secondary to the glycogenolytic effect. Biochem J. 1995 Jun 15;308(Pt 3):889–894. doi: 10.1042/bj3080889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rashed S. M., Patel T. B. Regulation of hepatic energy metabolism by epidermal growth factor. Eur J Biochem. 1991 May 8;197(3):805–813. doi: 10.1111/j.1432-1033.1991.tb15975.x. [DOI] [PubMed] [Google Scholar]
  24. Rasmussen T. N., Jørgensen P. E., Almdal T., Kirkegaard P., Olsen P. S. Stimulatory effect of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Scand J Gastroenterol. 1992 May;27(5):372–374. doi: 10.3109/00365529209000090. [DOI] [PubMed] [Google Scholar]
  25. Richman R. A., Claus T. H., Pilkis S. J., Friedman D. L. Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3589–3593. doi: 10.1073/pnas.73.10.3589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Soler C., Poveda B., Pastor-Anglada M., Soley M. Effect of epidermal growth factor (EGF) on gluconeogenesis in isolated rat hepatocytes. Dependency on the red-ox state of the substrate. Biochim Biophys Acta. 1991 Jan 31;1091(2):193–196. doi: 10.1016/0167-4889(91)90061-2. [DOI] [PubMed] [Google Scholar]
  27. Soler C., Soley M. Rapid and delayed effects of epidermal growth factor on gluconeogenesis. Biochem J. 1993 Sep 15;294(Pt 3):865–872. doi: 10.1042/bj2940865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Soley M., Hollenberg M. D. Epidermal growth factor (urogastrone)-stimulated gluconeogenesis in isolated mouse hepatocytes. Arch Biochem Biophys. 1987 May 15;255(1):136–146. doi: 10.1016/0003-9861(87)90303-1. [DOI] [PubMed] [Google Scholar]
  29. St Hilaire R. J., Hradek G. T., Jones A. L. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high-capacity uptake system. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3797–3801. doi: 10.1073/pnas.80.12.3797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Staddon J. M., Hansford R. G. Evidence indicating that the glucagon-induced increase in cytoplasmic free Ca2+ concentration in hepatocytes is mediated by an increase in cyclic AMP concentration. Eur J Biochem. 1989 Jan 15;179(1):47–52. doi: 10.1111/j.1432-1033.1989.tb14519.x. [DOI] [PubMed] [Google Scholar]
  31. Studer R. K., Borle A. B. Differences between male and female rats in the regulation of hepatic glycogenolysis. The relative role of calcium and cAMP in phosphorylase activation by catecholamines. J Biol Chem. 1982 Jul 25;257(14):7987–7993. [PubMed] [Google Scholar]
  32. Tebar F., Ramírez I., Soley M. Epidermal growth factor modulates the lipolytic action of catecholamines in rat adipocytes. Involvement of a Gi protein. J Biol Chem. 1993 Aug 15;268(23):17199–17204. [PubMed] [Google Scholar]
  33. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991 Aug 25;266(24):15771–15781. [PubMed] [Google Scholar]
  34. Tuomela T. Epidermal growth factor concentrations in submandibular salivary gland, plasma, liver, bile, kidneys and urine of male mice: dynamics after phenylephrine injection. Life Sci. 1990;46(17):1197–1206. doi: 10.1016/0024-3205(90)90494-c. [DOI] [PubMed] [Google Scholar]
  35. Yoshimoto K., Nakamura T., Ichihara A. Reciprocal effects of epidermal growth factor on key lipogenic enzymes in primary cultures of adult rat hepatocytes. Induction of glucose-6-phosphate dehydrogenase and suppression of malic enzyme and lipogenesis. J Biol Chem. 1983 Oct 25;258(20):12355–12360. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES